Xcout Intel
Verastem Oncology
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Subscribe to see Verastem Oncology’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Verastem Oncology at a glance
Verastem Oncology is a biotech company headquartered in United States, founded in 2010. Xcout tracks 10 named people at Verastem Oncology, including Dan Paterson (President and Chief Executive Officer). Xcout recorded 1 job posting from Verastem Oncology in the last 90 days.
Verastem Oncology leadership
- Dan PatersonPresident and Chief Executive Officer
- Michael KauffmanPresident, Development
- Dan CalkinsChief Financial Officer
- Cathy CarewChief Organizational Effectiveness Officer
- Daniel LyonsChief Commercial Officer
- John HayslipChief Medical Officer
4 more named people on record for Verastem Oncology, with roles, board committees and tenure — see the full roster →
Hiring at Verastem Oncology
Xcout recorded 1 job posting from Verastem Oncology in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Verastem Oncology's hiring signals →
Verastem Oncology competitors
A few of Verastem Oncology's closest competitors — see the full list of competitors and alternatives →
BreStem Therapeutics, Inc. is a clinical-stage biotechnology company located in Raleigh, North Carolina, focused on developing novel therapeutics to fight various diseases.
PIC Therapeutics, Inc. is a biopharmaceutical company headquartered in Natick, Massachusetts, dedicated to developing life-changing medicines for patients with cancer. The company focuses on oncology research and therapeutic product development.
Curis, Inc. is a biotechnology company headquartered in Lexington, Massachusetts. The company is engaged in the research and development of drug candidates for the treatment of human cancers.
AUM Biosciences is a clinical-stage biotechnology company that develops precision oncology therapeutics utilizing multi-faceted inhibition strategies to overcome cancer drug resistance. The company serves patients and the healthcare sector by advancing a targeted clinical pipeline designed to combat tumor evasion and treatment resistance.
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Revolution Medicines is a clinical-stage oncology company that develops novel targeted therapies to outsmart cancer. The company focuses on discovering and advancing therapeutic pipelines for patients with difficult-to-treat tumors.
Get Verastem Oncology's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Verastem Oncology? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Verastem Oncology in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access